Risk of Late Toxicity in Men Receiving Dose-Escalated Hypofractionated Intensity Modulated Prostate Radiation Therapy: Results From a Randomized Trial
International Journal of Radiation Oncology*Biology*Physics2014Vol. 88(5), pp. 1074–1084
Citations Over TimeTop 1% of 2014 papers
Karen E. Hoffman, Khinh Ranh Voong, Thomas J. Pugh, Heath D. Skinner, Lawrence B. Levy, Vinita Takiar, Seungtaek Choi, Weiliang Du, Steven J. Frank, Jennifer L. Johnson, J. Kanke, Rajat J. Kudchadker, Andrew K. Lee, Usama Mahmood, Sean E. McGuire, Deborah A. Kuban
Related Papers
- → Investigation on baseline toxicity to rats based on aliphatic compounds and comparison with toxicity to fish: Effect of exposure routes on toxicity(2014)10 cited
- [ASC-J9 for castration-resistant prostate cancer].(2014)
- Androgen Receptor Antagonists for the Treatment of Prostate Cancer(2012)
- → Circulating Tumor Cells in Prostate Cancer(2021)